Ahead of the Bell: FDA to Rule on Eli Lilly and Company Drug

September 26, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON - Eli Lilly executives are bracing Friday for a government decision on the company's blood thinner prasugrel, a potential blockbuster drug which regulators already have delayed once.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory

Eli Lilly and Company Food and Drug Administration (FDA)